North Korea is expected to receive nearly two million doses of AstraZeneca-Oxford Covid-19 vaccine by the first half of 2021, Yonhap has reported, citing a report published by Covax Facility on Wednesday.
The Covax Facility will distribute 1.992 million doses of AstraZeneca/Oxford vaccines produced by the Serum Institute of India to the North Korea by the first half, the news report said.
